Daniel Dale Kenneth Lingwood, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Antigen, B-Cell | 9 | 2023 | 544 | 2.590 |
Why?
|
Influenza Vaccines | 12 | 2024 | 767 | 2.550 |
Why?
|
Influenza A virus | 5 | 2024 | 458 | 2.400 |
Why?
|
Influenza, Human | 13 | 2024 | 1518 | 1.780 |
Why?
|
Membrane Microdomains | 7 | 2014 | 206 | 1.690 |
Why?
|
Antibodies, Neutralizing | 16 | 2024 | 1936 | 1.550 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 9 | 2024 | 158 | 1.320 |
Why?
|
Antibodies, Viral | 16 | 2024 | 3150 | 1.320 |
Why?
|
B-Lymphocytes | 13 | 2024 | 4745 | 1.270 |
Why?
|
AIDS Vaccines | 4 | 2024 | 896 | 1.130 |
Why?
|
Vaccines, Virus-Like Particle | 2 | 2024 | 43 | 0.980 |
Why?
|
Cell Membrane | 5 | 2014 | 3680 | 0.820 |
Why?
|
RNA Phages | 1 | 2021 | 3 | 0.790 |
Why?
|
Gills | 3 | 2006 | 21 | 0.770 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 254 | 0.760 |
Why?
|
Protein Engineering | 2 | 2021 | 548 | 0.710 |
Why?
|
Immunoglobulin Variable Region | 2 | 2024 | 419 | 0.700 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 3 | 2006 | 477 | 0.620 |
Why?
|
Orthomyxoviridae | 2 | 2024 | 149 | 0.580 |
Why?
|
Immunity, Humoral | 7 | 2024 | 600 | 0.550 |
Why?
|
Vaccination | 6 | 2024 | 3370 | 0.540 |
Why?
|
Galactosylceramides | 2 | 2006 | 92 | 0.510 |
Why?
|
Germinal Center | 4 | 2022 | 380 | 0.480 |
Why?
|
Sperm Capacitation | 1 | 2014 | 21 | 0.480 |
Why?
|
Antigens | 5 | 2022 | 1441 | 0.480 |
Why?
|
Carbohydrates | 1 | 2016 | 390 | 0.470 |
Why?
|
Epitopes | 9 | 2024 | 2501 | 0.470 |
Why?
|
Lipocalins | 1 | 2014 | 161 | 0.440 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 250 | 0.430 |
Why?
|
Allosteric Regulation | 1 | 2014 | 427 | 0.420 |
Why?
|
HIV Antigens | 3 | 2024 | 325 | 0.420 |
Why?
|
Cholesterol | 7 | 2011 | 2903 | 0.420 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 2202 | 0.410 |
Why?
|
Mice, Transgenic | 5 | 2023 | 9529 | 0.390 |
Why?
|
Sphingolipids | 3 | 2010 | 173 | 0.380 |
Why?
|
Membrane Lipids | 2 | 2009 | 252 | 0.370 |
Why?
|
Detergents | 3 | 2010 | 236 | 0.370 |
Why?
|
Eukaryota | 1 | 2011 | 102 | 0.360 |
Why?
|
Interleukin-6 | 1 | 2020 | 3206 | 0.360 |
Why?
|
Dendritic Cells | 2 | 2020 | 2722 | 0.350 |
Why?
|
Glycolipids | 1 | 2011 | 206 | 0.350 |
Why?
|
Oncogene Proteins | 1 | 2014 | 718 | 0.350 |
Why?
|
Virus Internalization | 3 | 2022 | 497 | 0.340 |
Why?
|
Complementarity Determining Regions | 4 | 2024 | 149 | 0.340 |
Why?
|
Influenza A Virus, H5N1 Subtype | 3 | 2015 | 113 | 0.340 |
Why?
|
Lipid Bilayers | 5 | 2011 | 383 | 0.330 |
Why?
|
Immunoglobulin Heavy Chains | 3 | 2019 | 647 | 0.310 |
Why?
|
Oncorhynchus mykiss | 2 | 2005 | 20 | 0.300 |
Why?
|
Seawater | 2 | 2005 | 124 | 0.300 |
Why?
|
Mice | 19 | 2024 | 81368 | 0.280 |
Why?
|
Vaccines | 1 | 2016 | 838 | 0.280 |
Why?
|
Animals | 28 | 2024 | 168201 | 0.280 |
Why?
|
Antibody Formation | 2 | 2024 | 1390 | 0.280 |
Why?
|
Membrane Proteins | 8 | 2020 | 7847 | 0.270 |
Why?
|
Cell Fractionation | 1 | 2007 | 249 | 0.270 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1132 | 0.260 |
Why?
|
Antibody Affinity | 2 | 2019 | 246 | 0.250 |
Why?
|
HIV Envelope Protein gp120 | 3 | 2024 | 914 | 0.250 |
Why?
|
Antigens, Viral | 4 | 2022 | 987 | 0.240 |
Why?
|
Acclimatization | 1 | 2005 | 113 | 0.240 |
Why?
|
Sulfoglycosphingolipids | 1 | 2004 | 29 | 0.240 |
Why?
|
Models, Biological | 4 | 2014 | 9461 | 0.240 |
Why?
|
Polysaccharides | 3 | 2022 | 1013 | 0.240 |
Why?
|
Immunoglobulin M | 3 | 2020 | 1526 | 0.230 |
Why?
|
Cross Reactions | 3 | 2020 | 816 | 0.220 |
Why?
|
Antibody Specificity | 2 | 2021 | 1058 | 0.220 |
Why?
|
Mannose-Binding Lectin | 2 | 2022 | 145 | 0.220 |
Why?
|
Fishes | 1 | 2006 | 602 | 0.210 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1703 | 0.210 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 860 | 0.210 |
Why?
|
Immunoglobulins | 1 | 2006 | 850 | 0.210 |
Why?
|
HIV Infections | 4 | 2024 | 17337 | 0.210 |
Why?
|
Coronavirus | 2 | 2021 | 156 | 0.200 |
Why?
|
Phospholipids | 1 | 2006 | 786 | 0.200 |
Why?
|
Saponins | 1 | 2021 | 45 | 0.200 |
Why?
|
Ligands | 3 | 2022 | 3268 | 0.200 |
Why?
|
Lymph | 1 | 2021 | 77 | 0.190 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2802 | 0.190 |
Why?
|
Autophagy | 1 | 2009 | 1326 | 0.190 |
Why?
|
Fresh Water | 3 | 2006 | 82 | 0.190 |
Why?
|
Alleles | 2 | 2022 | 6861 | 0.180 |
Why?
|
Bacteria | 1 | 2011 | 2192 | 0.180 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6520 | 0.180 |
Why?
|
HIV-1 | 4 | 2024 | 6858 | 0.180 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2020 | 26 | 0.170 |
Why?
|
Amino Acid Substitution | 1 | 2024 | 1739 | 0.170 |
Why?
|
Toll-Like Receptor 7 | 1 | 2020 | 165 | 0.170 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 261 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Humans | 42 | 2024 | 760617 | 0.160 |
Why?
|
Signal Transduction | 3 | 2020 | 23416 | 0.160 |
Why?
|
Lentivirus | 1 | 2022 | 507 | 0.160 |
Why?
|
Cell Line | 5 | 2020 | 15576 | 0.160 |
Why?
|
Adoptive Transfer | 1 | 2021 | 818 | 0.160 |
Why?
|
Epitope Mapping | 1 | 2019 | 297 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
Gene Library | 1 | 2021 | 1055 | 0.160 |
Why?
|
Homeostasis | 1 | 2009 | 3321 | 0.150 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 363 | 0.150 |
Why?
|
Immunoconjugates | 1 | 2006 | 951 | 0.150 |
Why?
|
Toll-Like Receptors | 1 | 2021 | 575 | 0.150 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 640 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 799 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 365 | 0.150 |
Why?
|
Nanoparticles | 5 | 2022 | 1957 | 0.150 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1300 | 0.150 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17629 | 0.150 |
Why?
|
Amino Acid Sequence | 5 | 2015 | 13441 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 597 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 578 | 0.140 |
Why?
|
Immunization, Secondary | 1 | 2019 | 368 | 0.140 |
Why?
|
Goblet Cells | 1 | 2020 | 298 | 0.140 |
Why?
|
Nasal Mucosa | 1 | 2020 | 415 | 0.140 |
Why?
|
Adaptive Immunity | 1 | 2021 | 724 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2022 | 2546 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 445 | 0.140 |
Why?
|
Adjuvants, Immunologic | 1 | 2021 | 990 | 0.130 |
Why?
|
Interferon Type I | 1 | 2020 | 557 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1348 | 0.120 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 974 | 0.120 |
Why?
|
HIV Antibodies | 4 | 2024 | 1302 | 0.120 |
Why?
|
Gangliosidosis, GM1 | 1 | 2014 | 11 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2022 | 2447 | 0.120 |
Why?
|
Single-Chain Antibodies | 1 | 2015 | 111 | 0.120 |
Why?
|
Basement Membrane | 2 | 2005 | 349 | 0.110 |
Why?
|
Models, Molecular | 4 | 2015 | 5433 | 0.110 |
Why?
|
Water-Electrolyte Balance | 2 | 2005 | 325 | 0.110 |
Why?
|
Liposomes | 2 | 2018 | 784 | 0.100 |
Why?
|
Binding Sites, Antibody | 1 | 2012 | 337 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2015 | 2178 | 0.100 |
Why?
|
Sperm Maturation | 1 | 2011 | 22 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1852 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1454 | 0.090 |
Why?
|
Mice, Inbred BALB C | 4 | 2022 | 6188 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 22115 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2022 | 2222 | 0.090 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 398 | 0.090 |
Why?
|
Lipoylation | 1 | 2010 | 87 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3688 | 0.090 |
Why?
|
Molecular Conformation | 1 | 2011 | 544 | 0.080 |
Why?
|
Vaccines, Inactivated | 2 | 2024 | 178 | 0.080 |
Why?
|
Spectrometry, Fluorescence | 2 | 2009 | 685 | 0.080 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2022 | 82 | 0.080 |
Why?
|
Chromatography, Thin Layer | 2 | 2006 | 213 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4739 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1355 | 0.080 |
Why?
|
Phase Transition | 1 | 2008 | 71 | 0.080 |
Why?
|
Immunoglobulin G | 3 | 2020 | 4533 | 0.080 |
Why?
|
G(M1) Ganglioside | 1 | 2008 | 87 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4571 | 0.080 |
Why?
|
Organelles | 1 | 2009 | 266 | 0.070 |
Why?
|
Complement System Proteins | 2 | 2022 | 734 | 0.070 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3045 | 0.070 |
Why?
|
Diffusion | 1 | 2008 | 814 | 0.070 |
Why?
|
Polysorbates | 1 | 2006 | 44 | 0.070 |
Why?
|
Micelles | 1 | 2007 | 192 | 0.070 |
Why?
|
Horseradish Peroxidase | 1 | 2006 | 166 | 0.070 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.060 |
Why?
|
Cholera Toxin | 1 | 2008 | 559 | 0.060 |
Why?
|
Cerebroside-Sulfatase | 1 | 2005 | 15 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2895 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2010 | 982 | 0.060 |
Why?
|
Solubility | 1 | 2007 | 1089 | 0.060 |
Why?
|
Protein Binding | 2 | 2016 | 9345 | 0.060 |
Why?
|
Protein Conformation | 1 | 2012 | 3965 | 0.060 |
Why?
|
Macaca mulatta | 2 | 2021 | 2328 | 0.060 |
Why?
|
Levivirus | 1 | 2024 | 14 | 0.060 |
Why?
|
Biological Evolution | 1 | 2010 | 1070 | 0.060 |
Why?
|
Hemagglutinins | 1 | 2024 | 111 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 1074 | 0.060 |
Why?
|
Osmolar Concentration | 1 | 2004 | 659 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 243 | 0.050 |
Why?
|
Rats | 3 | 2021 | 23717 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2020 | 11514 | 0.050 |
Why?
|
Shiga Toxins | 1 | 2002 | 40 | 0.050 |
Why?
|
Trihexosylceramides | 1 | 2002 | 31 | 0.050 |
Why?
|
HeLa Cells | 1 | 2009 | 3087 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1971 | 0.050 |
Why?
|
Vaccines, Attenuated | 1 | 2024 | 315 | 0.050 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2010 | 2446 | 0.050 |
Why?
|
Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
Erythrocytes | 1 | 2011 | 2410 | 0.050 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2024 | 369 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10760 | 0.050 |
Why?
|
Epithelium | 1 | 2005 | 1603 | 0.050 |
Why?
|
Biology | 1 | 2022 | 290 | 0.040 |
Why?
|
Dibenzothiepins | 1 | 2020 | 8 | 0.040 |
Why?
|
Thiepins | 1 | 2020 | 5 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2008 | 1901 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.040 |
Why?
|
Complement Fixation Tests | 1 | 2018 | 68 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1662 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5110 | 0.040 |
Why?
|
Glycosylation | 1 | 2022 | 1098 | 0.040 |
Why?
|
Lipids | 1 | 2009 | 3332 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2024 | 959 | 0.040 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.040 |
Why?
|
Receptors, Complement | 1 | 2018 | 253 | 0.040 |
Why?
|
Female | 8 | 2022 | 392148 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2011 | 3842 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17878 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2021 | 1848 | 0.040 |
Why?
|
Triazines | 1 | 2020 | 311 | 0.040 |
Why?
|
Amino Acids | 1 | 2024 | 1717 | 0.040 |
Why?
|
Seasons | 1 | 2024 | 1518 | 0.040 |
Why?
|
Oxazines | 1 | 2020 | 349 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2020 | 978 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3800 | 0.030 |
Why?
|
Methyltransferases | 1 | 2020 | 373 | 0.030 |
Why?
|
Morpholines | 1 | 2020 | 581 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2020 | 639 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 833 | 0.030 |
Why?
|
Male | 5 | 2022 | 360358 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1490 | 0.030 |
Why?
|
Ferrets | 1 | 2015 | 177 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1022 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2414 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 808 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2286 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2191 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 18937 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 933 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 2015 | 283 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2838 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2018 | 1118 | 0.030 |
Why?
|
Up-Regulation | 1 | 2020 | 4117 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5463 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4354 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4269 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8645 | 0.020 |
Why?
|
Laurates | 1 | 2009 | 7 | 0.020 |
Why?
|
2-Naphthylamine | 1 | 2009 | 20 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7196 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4366 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4341 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1914 | 0.020 |
Why?
|
Molecular Dynamics Simulation | 1 | 2011 | 437 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10073 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2874 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8833 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3039 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2015 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4408 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9172 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5822 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4642 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10505 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2624 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7373 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2014 | 5863 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15828 | 0.010 |
Why?
|
Hydroxylation | 1 | 2002 | 137 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9998 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18221 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12661 | 0.010 |
Why?
|
Aged | 2 | 2023 | 169042 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3567 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 220584 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58894 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16967 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64568 | 0.010 |
Why?
|
Child | 1 | 2020 | 80079 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88234 | 0.010 |
Why?
|
Adult | 1 | 2020 | 220969 | 0.000 |
Why?
|